Full-Time
Posted on 5/2/2025
Develops and manufactures biopharmaceutical products
$71.7k - $180.2k/yr
Junior, Mid
No H1B Sponsorship
Montgomery, IL, USA
Candidates must live within 25 miles of the border of the territory.
Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its partnership with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also initiatives to ensure that vaccines reach underserved populations. The company's goal is to continuously expand its range of healthcare solutions while maintaining a commitment to improving public health.
Company Size
10,001+
Company Stage
IPO
Headquarters
New York City, New York
Founded
1849
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Sick Leave
Paid Holidays
Hybrid Work Options
Relocation Assistance
Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding
Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The
The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.
The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.
New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is